Targeting Phage Therapy 2023: Where are we today and what's next?
The 6th World Congress on Targeting Phage Therapy 2023 has returned to present all aspects related to phages and phage therapy on June 1-2 in Paris, France.
It will highlight the recent innovations and clinical applications of phages, validation and limitations. Paris Targeting Phage Therapy 2023 will also cover how phage will transform the medicine of tomorrow.
International phage therapy and infectious disease experts will cover the following points:
- Phage Therapy: Recent Advances & Challenges
- Bacteriophage Characterization & Isolation
- Co-Evolutionary Mechanisms of Bacteria and Phages
- Bacteriophages & Microbiota: On the Way to a Medical Revolution?
- Bacteriophage Prophylactic & Therapeutic Applications
- Phages, Radiotherapy & Wound Healing
Bacteriophages & Microbiota: On the Way to a Medical Revolution?
In collaboration with the International Society of Microbiota (ISM), a session will be dedicated to how phage will modulate the quality and quantity of microbiota. We will also discuss how to select the adequate phage to target microbiota dysbiosis in disease.
Paris Targeting Phage Therapy 2023 Speakers
Targeting Phage Therapy 2023 will gather a group of academic and industrial professionals worldwide to discuss their most recent research and data.
Academic Speakers:
Domenico Frezza, University of Roma Tor Vergata, Italy |
Martha Clokie, University of Leicester, United Kingdom Phage Therapy & Its Applications: Where We Are Now and What’s Next? |
William Summers, Yale University, USA |
Tristan Ferry, Hospices Civils de Lyon, France The Use of Bacteriophage Therapy for Complex Bacterial Infections: the PHAGEinLYON Experience |
Anna Pistocchi, Università degli Studi di Milano, Italy |
Rodrigo Ibarra Chavez, University of Copenhagen, Denmark Phage-inducible Chromosomal Islands Promote Genetic Variability by Blocking Phage Reproduction |
Lilian Musila, U.S. Army Medical Research Directorate, Kenya Potential of Therapeutic Phages to Combat MDR ESKAPE Pathogens in Developing Nations |
Jean-Paul Pirnay, Queen Astrid Military Hospital, Belgium |
Aleksandra Petrovic Fabijan, Westmead Institute for Medical Research, Australia |
Noemi Poerio, University of Rome Tor Vergata, Italy |
Ryszard Międzybrodzki, Hirszfeld Institute of Immunology and Experimental Therapy PAS, Poland |
Anders S. Nilsson, Stockholm University, Sweden Novel Computer Program for Modelling Bacteriophage Infection Kinetics |
Farzaneh Moghtader, Istinye University, Turkey |
Willem-Jan Metsemakers, KU Leuven, Belgium |
Mzia Kutateladze, Eliava Institute of Bacteriophage, Georgia Phage Therapy: History in the Soviet Unions and Potential Treatment of Human Infections |
Industrials: |
Alexander Sulakvelidze, President and CEO of Intralytix, Inc., USA Modern Approaches for Optimizing Therapeutic Phage Preparations |
Jessica Sacher, cofounder of Phage Directory, Australia |
David Jernigan, PhagenCorp, LLC, USA Inducing Native Phages From the Human Virome to Address Targeted Infections |
Pranav Johri, Founder of Vitalis Phage Therapy, India From Patient to Advocate – Introducing Phage Therapy to India |
Present Your Innovations: 10 Minutes to Convince
During the Paris Targeting Phage Therapy 2023, a session will be dedicated to the latest innovations in the field of phages and phage therapy.
If you are academics, industrialists or representatives of startups, the scientific committee of Phage Therapy 2023 invites you to present your latest innovation in 10 minutes.
Tracks for abstract submission.
Institutional Partners
This meeting is organized under the endorsement of the International Society of Microbiota (ISM).
Contact Us
In case you needed any further information on the registration, program, or abstract submission please visit our website.
You can also directly contact the organizing committee via email: contact@tid-site.com.
Find more information on our social media: LinkedIn and Facebook.
SEE
No comments:
Post a Comment